For the year, the company reported profit of $887.9 million, or $10.67 per share. Revenue was reported as $3.9 billion. Idexx expects full-year earnings to be $11.74 to $12.24 per share, with revenue ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results.

IDEXX Laboratories, Inc.’s IDXX share price has surged by 11.13%, which has investors questioning if this is right time to ...

Learn more about whether IDEXX Laboratories, Inc. or Zimmer Biomet Holdings, Inc. is a better investment based on AAII's A+ ...

IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to ...

IDEXX Laboratories, Inc. , a global leader in pet healthcare innovation, today announced the launch of IDEXX Cancer Dxtm, a first-of-its-kind diagnostic panel with early detection of lymphoma in dogs, ...

sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories, Inc. (IDXX), valued at ... and water testing markets. The Westbrook, Maine-based company also sells a series of portable electrolytes and blood gas analyzers for the human ...

Equities research analysts at William Blair decreased their Q1 2025 earnings per share estimates for shares of IDEXX ...